ALT 8-K 2026-09-29

Altimmune, Inc. (ALT) 8-K dated 2026-09-29 — accession 0001326190-26-000056. This URL is the filing, not the ALT hub.

Altimmune, Inc. (ALT) is a biotechnology company listed on US.

Altimmune, Inc. filed a 8-K on 2026-09-29. Accession 0001326190-26-000056.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALT revenue for 2025-12-31 was $41.0K. Net income was -$88.1M. Revenue was up 105.0% from 2024-12-31 to 2025-12-31. ALT currently screens at market cap $527.0M.

Not investment advice. The ALT SEC hub lists recent forms. The stock page is the research view.